ESC 365 - State-of-the-art lecture - Which antiplatelet agents in acute coronary syndromes? And when to start?

ESC Premium Access

State-of-the-art lecture - Which antiplatelet agents in acute coronary syndromes? And when to start?

Session: Which P2Y12 Inhibitor for Patients with Acute Coronary Syndromes?

Topic: Acute Coronary Syndromes

Speaker: Professor G. Montalescot (Paris, FR)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

35 presentations

1 follower

2 more presentations in this session

Case 1 - My P2Y12 inhibitor choice for a patient presenting with NSTEMI.

Speaker: Professor S. Schuepke (Munich, DE)

Case 2 - My P2Y12 inhibitor choice for a patient presenting with STEMI.

Speaker: Professor Z. Motovska (Prague, CZ)

Access the full session

Which P2Y12 Inhibitor for Patients with Acute Coronary Syndromes?

Speakers: Professor G. Montalescot, Professor S. Schuepke, Professor Z. Motovska

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources